Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page footer shows a new revision label (Revision: v3.3.2) and the previous label (v3.2.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA government funding/operating status notice has been removed from the page. The core study details, eligibility criteria, and results-related information remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show cosmetic UI updates and refreshed metadata while core study data such as enrollment numbers, status, eligibility, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a version update to v3.2.0; removed several disease names and the prior revision tag v3.1.0.SummaryDifference5%

- Check78 days agoChange DetectedThe page updated disease names from older terms to newer standardized terms (e.g., replacing Acute lymphoblastic leukemia with Acute lymphoid leukemia) and updated the version from v3.0.2 to v3.1.0.SummaryDifference0.4%

- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.3%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.